Pneumococcal Antibody Response Thresholds for Inadequate Immune Response

Standard Criteria for Adequate Response

An inadequate immune response to pneumococcal vaccination is defined as failure to achieve a 4-fold increase in antibody titers to at least 70% of tested serotypes, though this traditional criterion may be overly stringent and should be interpreted alongside absolute post-vaccination titers of ≥1.3 μg/mL per serotype 1, 2
At least a 4-fold increase in antibody titers for protein antigens is recommended 1, 2
Post-vaccination antibody concentrations ≥1.3 μg/mL per serotype is associated with protection against invasive pneumococcal infections 1, 2
Response to ≥70% of tested pneumococcal serotypes when using the 4-fold increase criterion is considered adequate 3

Absolute post-vaccination titers ≥1.3 μg/mL are protective against invasive disease, even without achieving a 4-fold increase 1, 2
Lower thresholds of 0.35 μg/mL have been associated with protection against invasive infections, though not against mucosal infections like otitis media and sinusitis 1, 2

In immunocompromised populations, such as SLE patients, a 2-fold increase in antibody titer was observed in only 20% of patients versus 50% of controls 4, 5, 6
Less than 40% of SLE patients had adequate immune responses when defined as a 4-fold increase in at least 70% of serotype-specific IgG responses 3
Between 36.0% to 97.6% immunogenicity was reported depending on assay methodology and timing 4, 5, 6, 7

Postvaccination levels should be determined 3-4 weeks (or 4-6 weeks) after immunization 1, 2
Long-term protection may wane, with some studies showing 42% of SLE patients falling below protective thresholds at 3 years post-vaccination 3

Different laboratory assays yield different results (ELISA, radioimmunoassay, multiplex fluorescent microsphere immunoassays), making cross-study comparisons challenging 4, 5, 6
Consider opsonophagocytic activity testing in addition to antibody titers for a more functional assessment of immunity 4, 5, 6